Skip to content

Author

M. B. Sufi

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

To Develop and Validate the Stability Indicating Method for Ezetimibe and Rosuvastatin Using HPLC Method

A reverse-phase HPLC (RP-HPLC) method has been developed and validated which is simple, fast, accurate of Rosuvastatin and Ezetimibe in the pharmaceutical tablet dose. The separation was done on C18 column (250 × 4.6 mm, 5 µm) with Methanol acid (60:40, v/v) as mobile phase flow rate of 1.0 mL/min at the isosbestic wav...

M. B. Sufi, Sakshi Bobade, Rajlaxmi Deolekara · 0 citations
Open access 2026

To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method

A simple, rapid, accurate, precise, robust and stability indicating Reverse phase High Performance Liquid Chromatography (RP-HPLC) method for the simultaneous estimation of Repaglinide and Voglibose in bulk drug and pharmaceutical dosage form was developed and validated. Chromatographic separation was achieved on a C18...

M. B. Sufi, Shantanu Burange, Rajlaxmi S. Deolekar · 0 citations
Open access 2026

To study the effect of Eudragit RL and RS in the formulation and Evaluation of Olmesartan Matrix Tablet

This study was aimed to formulate and evaluate sustained release matrix tablets of Olmesartan medoxomil using the release controlling polymers namely HPMC K15M, Eudragit RL and Eudragit RS for extended period release of drug and to enhance the patient compliance. For preformulation studies, absorption maximum (λmax), c...

M. B. Sufi, Mohd Julebib Mohd Shafique, Rajlaxmi · 0 citations
Open access 2026

To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method

The developed RP HPLC method is simple, rapid, selective, accurate, economical, and can be used for routine pharmaceutical quality control, stability testing and analysis of combined Linagliptin and Empagliflozin formulation.

M. B. Sufi, Vaishnavi Daldale, Irshad Ahmed · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.